On August 7, 2025, the U.S. stock market exhibited a complex trend. The three major indices showed varied performances, with the Dow Jones Industrial Average falling by 0.51% to close at 43968.64 points; the S&P 500 index slipped slightly by 0.08%, closing at 6340 points; while the Nasdaq Composite Index rose against the trend by 0.35%, closing at 21242.70 points, with an intraday gain exceeding 1% at one point.

The Volatility Index VIXY fell slightly by 0.78%, closing at 41.18, reflecting a relatively stable overall market sentiment.

Tech giants showed mixed results, but overall exhibited an upward trend. Apple's stock price surged by 3.18%, making it one of the best-performing large tech stocks of the day. Amazon and Google's parent company Alphabet's Class C shares also rose by 0.37% and 0.18%, respectively. Tesla's stock price increased moderately by 0.74%. However, Meta Platforms (formerly Facebook) fell by 1.32%, while Microsoft slipped slightly by 0.78%.

It is worth noting that the NASDAQ China Golden Dragon Index rose by 0.95%, indicating that Chinese concept stocks performed well overall.

The pharmaceutical sector has experienced significant volatility. Eli Lilly's stock price took a heavy hit, plummeting by 14.14%. This is mainly due to its oral weight-loss drug Orforglipron's experimental data falling short of expectations, with an average weight loss of only 11.2%. In stark contrast, competitor Novo Nordisk's stock price surged by 7.45%, highlighting investors' sensitive reaction to changes in the competitive landscape of the weight-loss drug market.

Overall, the trading day showed a relative strength in technology stocks, while biopharmaceutical stocks experienced significant fluctuations due to specific company news. Investors need to closely monitor the latest developments in various industries, as well as important economic data and company announcements that may affect market trends.